[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
About the Journal
Editorial Board
Aims& Scopes
Journal News
Articles archive::
All Issues
Current Issue
Publication Ethics::
Peer Review Process::
Indexing Databases::
For Authors::
Authors Guideline
Call for Papers
Submission Instruction
Review Process
Research Ethics Statements
Ethical issues
Author Complaint Process
For Reviewers::
Reviewers Section
Subscription::
Registration Information
Subscription Form
Contact us::
Contact Information
Contact us
Site Facilities::
Site map
Search contents
FAQ
Top 10 contents
Inform to friends
::
Google Scholar Metrics

Citation Indices from GS

AllSince 2019
Citations63793681
h-index2720
i10-index18882
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Registered in

AWT IMAGE

AWT IMAGE
..
:: Volume 32, Issue 1 (5-2024) ::
Journal of Ilam University of Medical Sciences 2024, 32(1): 66-74 Back to browse issues page
Comparison of enzymatic and non-enzymatic antioxidants in patients with squamous cell carcinoma and leukoplakia
Fariba Abdal1 , Mahsa Hamidi1 , Salar Bakhtiyari2 , Leila Naseri3 , Elham Shafiei * 4
1- Dept of oral and maxillofacial pathology, faculty of dentistry, Ilam university of medical sciences, Ilam, Iran
2- Dept of Biochemistry, Ilam university of medical sciences, , Ilam , Iran
3- Clinical research development unit, Ayatollah Taleghani Hospital, Ilam university of medical sciences, Ilam , Iran
4- Clinical research development unit, Ayatollah Taleghani Hospital, Ilam university of medical sciences, Ilam , Iran , shaFEIEM@YAHOO.COM
Abstract:   (93 Views)
Introduction:  Oral squamous cell carcinoma (OSCC) is the most common malignancy of the oral cavity, which is usually caused by the most common premalignant lesion of oral leukoplakia (OL). For changes of dysplasia and malignancy, the level of antioxidants in the blood and tissue of patients changes significantly, which may be effective in early diagnosis of malignancies. Therefore, the purpose of this study is to evaluate antioxidants (enzymatic and non-enzymatic) in the blood of patients with OSCC and OL.
Material & Methods: This study is a case-control study and was conducted on 75 blood samples of patients with OSCC and OL referred to the Cancer Institute of Imam Khomeini Hospital, Ilam. Enzymatic antioxidants [catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase (GPx)] and non-enzymatic antioxidants (ascorbic acid, beta-carotene, vitamin E) were evaluated in the blood of patients. The data obtained from this study were evaluated by ANOVA test and the significance level (P<0.5) was considered.
Results: The results showed that the mean age in the HC group was similar in both sexes, while in the OL group, the age of women was 4 years younger, and in the OSCC group, the age of women was 2 years older than men. CAT, as an antioxidant indicator, significantly increased in the OL group compared to the HC group and OSCC group (P < 0.000). Also, CAT and SOD activity in OSCC serum samples significantly decreased compared to the HC group (P < 0.000). GPx also showed a significant decrease in both OL and OSCC groups compared to the HC group (P < 0.000). The results related to the non-enzymatic antioxidant factors, beta-carotene, vitamin E, and ascorbic acid, significantly decreased in both OL and OSCC groups compared to the HC group (beta-carotene (P < 0.000), vitamin E (P < 0.000), and ascorbic acid (P < 0.000)).
Discussion & Conclusion: The results of this study show that the level of enzymatic antioxidants and beta-carotene in is not related to the degree of dysplasia of oral leukoplakia, therefore, it is not possible to predict the probability of occurrence of malignant oral lesions based on the measurement of the level of antioxidants in patients with OL.
Keywords: Antioxidant, Free radical, Squamous cell carcinoma, Leukoplakia
Full-Text [PDF 1163 kb]   (37 Downloads)    
Type of Study: Research | Subject: Clinical pathology
Received: 2022/11/27 | Accepted: 2024/04/16 | Published: 2024/05/4
References
1. Badwelan M, Muaddi H, Ahmed A, Lee KT, Tran SD. Oral Squamous Cell Carcinoma and Concomitant Primary Tumors, What Do We Know? A Review of the Literature. Curr Oncol 2023;30:3721-34. doi:10.3390/curroncol30040283.
2. Chen YT, Lin CW, Chou YE, Su SC, Chang LC, Lee CY, et al. Potential impact of ADAM‐10 genetic variants with the clinical features of oral squamous cell carcinoma. J Cell Mol Med 2023; 27:1144-52. doi: 10.1111/jcmm.17728. Epub 2023 Mar 22.
3. Folz BJ, Silver CE, Rinaldo A, Fagan JJ, Pratt LW, Weir N, et al. An outline of the history of head and neck oncology. Oral oncol 2008;44:2-9. doi: 10.1016/j.oraloncology.2007.05.007.
4. Lung T, Tăşcău OC, Almăşan HA, O M. Head and neck cancer, treatment, evolution and post therapeutic survival--part 2: a decade’s results 1993-2002. J Craniomaxillofac Surg 2007;35:126-31. doi: 10.1016/j.jcms.2007.02.002.
5. Warnakulasuriya S, Johnson NW, Van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007;36:575-80. doi: 10.1111/j.1600-0714.2007.00582.x.
6. Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol 2018;125:612-27. doi: 10.1016/j.oooo.2017.12.011.
7. Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma—an update. CA Cancer J Clin 2015;65:401-21. doi: 10.3322/caac.21293.
8. Porter S, Gueiros LA, Leão JC, Fedele S. Risk factors and etiopathogenesis of potentially premalignant oral epithelial lesions. Oral Surg Oral Med Oral Pathol Oral Radio 2018;125:603-11. doi: 10.1016/j.oooo.2018.03.008.
9. Moradzadeh Khiavi M, Anvari E, Hamishehkar H, Abdal K. Assessment of the Blood Parameters, Cardiac and Liver Enzymes in Oral Squamous Cell Carcinoma Following Treated with Injectable Doxorubicin-Loaded Nano-Particles. Asian Pac J Cancer Prev 2019;20:1973-7. doi: 10.31557/APJCP.2019.20.7.1973.
10. Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 2010;4:118. doi: 10.4103/0973-7847.70902.
11. Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med 2016;45:155-66. doi: 10.1111/jop.12339.
12. Kolanjiappan K, Ramachandran C, Manoharan S. Biochemical changes in tumor tissues of oral cancer patients. Clin Biochem 2003;36:61-5. doi: 10.1016/s0009-9120(02)00421-6.
13. Yadav KD, Patil BA, Raheel SA, Abuderman A, Patil S, Gaballah K, et al. Serum uric acid levels in patients with oral cancer, leukoplakia and submucous fibrosis: a cross-sectional study. Transl Cancer Res 2020;9:3084-91. doi: 10.21037/tcr.2020.01.08.
14. Gondos A, Arndt V, Holleczek B, Stegmaier C, Ziegler H, Brenner H. Cancer survival in Germany and the United States at the beginning of the 21st century: An up‐to‐date comparison by period analysis. Int J Cancer 2007;121:395-400. doi: 10.1002/ijc.22683.
15. Gokul S, Patil V, Jailkhani R, Hallikeri K, Kattappagari K. Oxidant–antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients. Oral Diseases 2010;16:29-33. doi:10.1111/j.1601-0825.2009.01598.x.
16. Kumar AT, Knops A, Swendseid B, Martinez-Outschoom U, Harshyne L, et al. Prognostic significance of tumor-associated macrophage content in head and neck squamous cell carcinoma: a meta-analysis. Front Oncol 2019; 23;9:656. doi: 10.3389/fonc.2019.00656.
17. Alateyah N, Gupta I, Rusyniak RS, Ouhtit A. SOD2, a potential transcriptional target underpinning CD44-promoted breast cancer progression. Molecules 2022; 27:811. doi: 10.3390/molecules27030811.
18. Yan T, Oberley LW, Zhong W, Clair DKS. Manganese-containing superoxide dismutase overexpression causes phenotypic reversion in SV40-transformed human lung fibroblasts. Cancer Res 1996;56:2864-71.
19. Gurudath S, Naik RM, Ganapathy K, Guruprasad Y, Sujatha D, Pai A. Superoxide dismutase and glutathione peroxidase in oral submucous fibrosis, oral leukoplakia, and oral cancer: A comparative study. Asian Pac J Cancer Prev 2012;13:4409-12. doi: 10.7314/apjcp.2012.13.9.4409.
20. Sharma Y, Bharadwaj M, Srivastava N, Kaur A, Kumar M, Agarwal M, et al. In vitro antioxidant activity of defatted seed extracts of Ocimum sanctum on rat PC-12 cells and its inhibitory efficacy with receptors of oral squamous cell carcinoma. Ind Crops Prod;154:112668. doi:10.1016/j.indcrop.2020.112668.
21. Raghavendra U, D'Souza V, D'souza B. Erythrocyte malondialdeyde and antioxidant status in oral squamous cell carcinoma patients and tobacco chewers/smokers. Biomed Res 2010;21:441-4.
22. Han Z, Zhao D, Han M, Zhang R, Hao Y. Knockdown of miR-372-3p Inhibits the Development of Diabetic Cardiomyopathy by Accelerating Angiogenesis via Activating the PI3K/AKT/mTOR/HIF-1α Signaling Pathway and Suppressing Oxidative Stress. Oxid Med Cell Longev 2022; :4342755. doi: 10.1155/2022/4342755.
23. Khanna R, Thapa PB, Khanna HD, Khanna S, Khanna AK, Shukla HS. Lipid peroxidation and antioxidant enzyme status in oral carcinoma patients. Kathmandu Univ Med J (KUMJ) 2005;3:334-9.
24. Cierpikowski P, Lis-Nawara A, Bar J. Prognostic Value of WNT1, NOTCH1, PDGFRβ, and CXCR4 in Oral Squamous Cell Carcinoma. Anticancer Res 2023;43:591-602. doi: 10.21873/anticanres.16195.
25. Rasheed MH, Beevi SS, Geetha A. Enhanced lipid peroxidation and nitric oxide products with deranged antioxidant status in patients with head and neck squamous cell carcinoma. Oral Oncol 2007;43:333-8. doi: 10.1016/j.oraloncology.
26. Burlakova EB, Zhizhina GP, Gurevich SM, Fatkullina LD, Kozachenko AI, Nagler LG, et al. Biomarkers of oxidative stress and smoking in cancer patients. J Cancer Res Ther 2010;6:47. doi: 10.4103/0973-1482.63569.
27. Metgud R, Bajaj S. Evaluation of salivary and serum lipid peroxidation, and glutathione in oral leukoplakia and oral squamous cell carcinoma. J Oral Sci 2014;56:135-42. doi: 10.2334/josnusd.56.135.
28. Buzby GP, Mullen JL, Stein TP, Miller EE, Hobbs CL, Rosato EF. Host‐tumor interaction and nutrient supply. Cancer 1980;45:2940-8. doi: 10.1002/1097-0142(19800615)45:12<2940::aid-cncr2820451208>3.0.co;2-p
29. MacDonald DG, PM S. Tumours of the oral cavity. In: Fletcher CD, editor. Diagnostic histopathology of tumors. 3 ed London: Churchill Livingstone;. 2007: 215-37.
30. Fiaschi AI, Cozzolino A, Ruggiero G, Giorgi G. Glutathione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci 2005;9:361.
31. Reddy VP. Oxidative Stress in Health and Disease. Biomedicines 2023;11:2925. doi: 10.3390/biomedicines11112925.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

Ethics code: IR.MEDILAM.REC.1400.096

XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Abdal F, Hamidi M, Bakhtiyari S, Naseri L, Shafiei E. Comparison of enzymatic and non-enzymatic antioxidants in patients with squamous cell carcinoma and leukoplakia. J. Ilam Uni. Med. Sci. 2024; 32 (1) :66-74
URL: http://sjimu.medilam.ac.ir/article-1-7793-en.html
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 32, Issue 1 (5-2024) Back to browse issues page
مجله دانشگاه علوم پزشکی ایلام Journal of Ilam University of Medical Sciences
Persian site map - English site map - Created in 0.16 seconds with 39 queries by YEKTAWEB 4646